The prognostic value of CD3 + tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study / Francini E, Ou FS, Lazzi S, Petrioli R, Multari AG, Pesola G, Messuti L, Colombo E, Livellara V, Bazzurri S, Cherri S, Miano ST, Wolfe EG, Alberts SR, Hubbard JM, Yoon HH, Francini G.. - In: TRANSLATIONAL ONCOLOGY. - ISSN 1944-7124. - STAMPA. - (2021), pp. 100973-100979.
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study.
Francini E
Writing – Original Draft Preparation
;Bazzurri S;
2021
Abstract
The prognostic value of CD3 + tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
CD3+ TILs Colon cancer adjuvant vs no adjuvant.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
660.54 kB
Formato
Adobe PDF
|
660.54 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
